16 July 2012
FDA Approves PrEP for HIV Prevention
Health
The US FDA approved Truvada for use as pre-exposure prophylaxis (PrEP) in HIV-negative adults at high risk of infection — the first drug approved specifically for HIV prevention in uninfected individuals. PrEP represented a paradigm shift in HIV prevention, giving people a pharmaceutical tool to protect themselves, and has since been credited with significantly reducing new HIV infections where widely available.
Impact & Significance
Revolutionised HIV prevention by putting a highly effective tool directly in the hands of those at risk, fundamentally changing public health strategy.
Reference Record
- Date
- 16 July 2012
- Era
- 2010-2019
- Sources
- 2
This timeline entry is being migrated into the reference platform. Source metadata and editorial review status will be strengthened as each topic is upgraded.
Questions This Event Helps Answer
Q How did HIV/AIDS shape LGBTQ+ history? HIV/AIDS shaped LGBTQ+ history through bereavement, stigma, public health campaigning, community care, treatment activism, and major medical advances. Q How did HIV/AIDS change public health and activism? HIV/AIDS changed public health by forcing faster surveillance, treatment approval, community-led prevention, visible memorialisation and international awareness.
